Rhinovirus vaccination: The case in favour

European Respiratory Journal

Volumn 37, Issue 1, 2011, Pages 3-4

  Rohde, G G U ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; VIRUS VACCINE;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; EDITORIAL; HUMAN; HUMAN RHINOVIRUS; INFLUENZA; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRAL RESPIRATORY TRACT INFECTION;

ANTIBODIES, VIRAL; HUMANS; NEUTRALIZATION TESTS; PEPTIDES; PICORNAVIRIDAE INFECTIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RHINOVIRUS; VACCINATION; VIRAL VACCINES; VIRUS DISEASES;

EID: 79251586842     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00136510     Document Type: Editorial

References (14)

1. Rohde G. Therapeutic targets in respiratory viral infections. Curr Med Chem 2007; 14: 2776-2782.
2. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993; 307: 982-986.
3. Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995; 310: 1225-1229.
4. Xepapadaki P, Papadopoulos NG. Childhood asthma and infection: virus-induced exacerbations as determinants and modifiers. Eur Respir J 2010; 36: 438-445.
5. Bizzintino J, Lee WM, Laing IA, et al., Association between human rhinovirus C and severity of acute asthma in children. Eur Respir J 2010; [Epub ahead of print DOI: 10.1183/09031936.00092410].
6. Seemungal T, Harper-Owen R, Bhowmik A, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1618-1623.
7. Rohde G, Wiethege A, Borg I, et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalization: a case-control study. Thorax 2003; 58: 37-42.
8. Sethi S. Infection as a comorbidity of COPD. Eur Respir J 2010; 35: 1209-1215.
9. Rohde G. Drug targets in rhinoviral infections. Infect Disord Drug Targets 2009; 9: 126-132.
10. Williams JM. 2009 update in prevention, evaluation, and outpatient treatment of influenza. Curr Med Res Opin 2009; 25: 817-828.
11. Palmenberg AC, Spiro D, Kuzmickas R, et al. Sequencing and analyses of all known human rhinovirus genomes reveals structure and evolution. Science 2009; 324: 55-59.
12. Rossmann MG, Arnold E, Erickson JW, et al. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 1985; 317: 145-153.
13. Edlmayr J, Niespodziana K, Popow-Kraupp T, et al., Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation. Eur Respir J 2011; 37: 44-52.
14. McCray J, Werner G. Different rhinovirus serotypes neutralized by antipeptide antibodies. Nature 1987; 329: 736-738.